Professional
Added to YB: 2024-09-02
Pitch date: 2024-06-30
CORT [bullish]
Corcept Therapeutics Incorporated
+83.72%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Corcept Therapeutics Incorporated, a biopharmaceutical company, engages in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic, and neurologic disorders in the United States.
Market Cap
$6.1B
Pitch Price
$32.49
Price Target
N/A
Dividend
N/A
EV/EBITDA
-1.3K
P/E
141.99
EV/Sales
7.31
Sector
Pharmaceuticals
Category
growth
Show full summary:
abrdn U.S. Small Cap Equity Fund New Position: Corcept Therapeutics Incorporated
CORT: Commercial-stage biopharma co specializing in Cushing's syndrome and cortisol-related diseases. Initiated position. Bull case: next-gen drug could increase market penetration.
Read full article (1 min)